Scheduled for 20-21 November 2026, the Global Digital Health Summit will take place in New Delhi, highlighting the role of artificial intel...

The last few weeks have made one thing clear. Oil prices, US bond yields, corporate earnings, and the state of the world – all point the sa...

Indian industry is poised for growth as German companies are encouraged to invest in manufacturing capacities. The upcoming India-European ...

For the better part of a decade now, every time this critical sector has run into trouble, the government has stepped in. The clean-up bega...

India's pharmaceutical companies are expected to have a mixed performance in the upcoming September quarter. Companies like Sun Pharmaceuti...

For millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...

Abakkus Mutual Fund’s Sanjay Doshi sees opportunities across market capitalisations, despite elevated mid- and smallcap valuations. He urge...

Look at how the market treated the stock of a large FMCG stock – one the best wealth creators of the past – just because it mentioned the r...

The next few weeks are critical, and one should not be in a hurry to make market-related decisions. Better to be cautious – to wait and wat...

As we see a recovery in the market, it is good to be cognizant of the fact that more than the narratives on the street, it is the earnings ...

Indian pharma and chemical companies at CPHI Milan say the China+1 opportunity is real, but a “missing middle” in the MSME ecosystem, marke...

Given the current global and domestic situation, the chances are that the volatility quotient in the market will remain high. So, the best ...

At CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated produc...

Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...

Anupam Rasayan India Ltd anticipates significant growth in its pharmaceutical segment over the next three years. The company expects pharma...

Linux Laboratories has secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. This investment involv...

Anupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...